No abstract available
MeSH terms
-
Affect / drug effects
-
Affect / physiology
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / pharmacology
-
Antipsychotic Agents / therapeutic use
-
Controlled Clinical Trials as Topic
-
Electric Stimulation Therapy
-
Glutamic Acid / metabolism
-
Glycine / metabolism
-
Glycine Plasma Membrane Transport Proteins / antagonists & inhibitors
-
Glycine Plasma Membrane Transport Proteins / metabolism
-
Happiness
-
Humans
-
Piperazines / pharmacology
-
Piperazines / therapeutic use
-
Pleasure / drug effects*
-
Pleasure / physiology
-
Risperidone / adverse effects
-
Risperidone / pharmacology
-
Risperidone / therapeutic use
-
Schizophrenia / drug therapy*
-
Schizophrenia / physiopathology*
-
Schizophrenic Psychology*
-
Sulfones / pharmacology
-
Sulfones / therapeutic use
-
Treatment Failure
-
alpha7 Nicotinic Acetylcholine Receptor / agonists
-
alpha7 Nicotinic Acetylcholine Receptor / metabolism
Substances
-
(4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone
-
Antipsychotic Agents
-
Glycine Plasma Membrane Transport Proteins
-
Piperazines
-
Sulfones
-
alpha7 Nicotinic Acetylcholine Receptor
-
Glutamic Acid
-
Risperidone
-
Glycine